These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32000425)

  • 1. Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis.
    Jin Y; Zhang J; Wang Y; Xiao X; Zhang Q
    Medicine (Baltimore); 2020 Jan; 99(5):e18970. PubMed ID: 32000425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.
    Liu S; Li X; Li H; Liang Q; Chen J; Chen J
    BMC Nephrol; 2015 Dec; 16():200. PubMed ID: 26637482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial.
    Geng C; Li Q; Pu L; Yang H; Li G; Feng Y
    Medicine (Baltimore); 2022 Feb; 101(6):e28842. PubMed ID: 35147131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.
    Shang SL; Cai GY; Duan SW; Li P; Li QG; Chen XM
    BMC Nephrol; 2018 Jul; 19(1):182. PubMed ID: 30021637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of
    Shi H; Hou Y; Su X; Qiao J; Wang Q; Guo X; Gao Z; Wang L
    Ren Fail; 2022 Dec; 44(1):116-125. PubMed ID: 35172688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
    Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
    BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research and prospect on reducing the toxicity and enhancing the efficacy of Tipterygium wilfordii by combined use of Chinese medicine].
    Li B; Zhou XX; Liang MX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Nov; 26(11):1045-8. PubMed ID: 17186742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.
    Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL
    Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials.
    Zheng W; Mei Y; Chen C; Cai L; Chen H
    Phytother Res; 2021 Jun; 35(6):2902-2924. PubMed ID: 33368709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
    Lu Z; Liu W; Gao H; Chen W; Ge W; Li F; Deng Y
    PLoS One; 2021; 16(5):e0251131. PubMed ID: 33989325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
    Jin D; Yu M; Li X; Wang X
    J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome.
    Wang XB; Dai EL; Xue GZ; Ma RL
    Medicine (Baltimore); 2018 Jul; 97(27):e11282. PubMed ID: 29979395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy: A protocol for systematic review and meta-analysis.
    Li K; Yu Y; Gao Y; Gao J
    Medicine (Baltimore); 2022 Feb; 101(8):e28891. PubMed ID: 35212292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Tripterygium wilfordii Hook F preparations for the treatment of Crohn disease: A systemic review and meta-analysis protocol.
    Zhang J; Han G; Yu Z
    Medicine (Baltimore); 2019 Jun; 98(26):e16231. PubMed ID: 31261581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism for the therapeutic effect of
    Zhao J; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):573-582. PubMed ID: 35753727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on therapeutic effects of huangdan decoction and Tripterygium Wilfordii compound tablet on membranous glomerulonephritis in rats.
    Zheng JF; Chen SY
    J Tongji Med Univ; 1995; 15(1):31-4. PubMed ID: 7783260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation.
    Gao Y; Liu Y; Guo Z; Zhang L
    Medicine (Baltimore); 2021 Dec; 100(51):e28157. PubMed ID: 34941066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy.
    Wang RX; Liao BQ; Chen W; Zhang YM; Tang XH; Xie FH
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8756-8770. PubMed ID: 36524494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.